Busy. Please wait.

show password
Forgot Password?

Don't have an account?  Sign up 

Username is available taken
show password


Make sure to remember your password. If you forget it there is no way for StudyStack to send you a reset link. You would need to create a new account.

By signing up, I agree to StudyStack's Terms of Service and Privacy Policy.

Already a StudyStack user? Log In

Reset Password
Enter the associated with your account, and we'll email you a link to reset your password.

Remove ads
Don't know
remaining cards
To flip the current card, click it or press the Spacebar key.  To move the current card to one of the three colored boxes, click on the box.  You may also press the UP ARROW key to move the card to the "Know" box, the DOWN ARROW key to move the card to the "Don't know" box, or the RIGHT ARROW key to move the card to the Remaining box.  You may also click on the card displayed in any of the three boxes to bring that card back to the center.

Pass complete!

"Know" box contains:
Time elapsed:
restart all cards

Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.

  Normal Size     Small Size show me how



Causes of vessel wall dz Scurvy (Vit C def); Amyloidosis; Hereditary-Hemorrhagic Teleangiectasia (Osler-Weber-Rendu Dz); Neurofibromatosis; Collagen Dz (Marfan; Ehler-Danlos)
micro-angiopathic hemolytic anemia (MAHA) lab findings TTP; anemia, hemolysis, schistocytes
Extrinsic & intrinsic coag pathways converge to form: factor Xa
All clotting factors (except FVIII) are made in: Liver
Effects of liver dz on coagulation 1st: decrease in factor VII (short half-life) prolongs PT; then decrease in other factors -> prolonged aPTT. Disease causes splenomegaly -> thrombocytopenia
MOA: warfarin tx on high PT Warfarin antagonizes the action of Vitamin K
Vitamin K is a necessary co-factor in the g-glutamyl carboxylation of: Factors II, VII, IX, X (these along with Ca & platelets activate FX & FII in coag cascade). Also Protein C and Protein S
MOA of vitamin K deficiency on high PT Similar to MOA of warfarin
Deficiencies in HMWK, PK, and FXII are assoc w/which bleeding problems? Deficiencies in HMWK, PK, and FXII are NOT associated with any bleeding
Clotting factor def assoc w/Jewish ancestry FXI def
Factor VIII deficiency AKA: Hemophilia A
Factor IX deficiency AKA: Hemophilia B
FVIII & FIX deficiency: percentages associated with bleeding & severity <1% assoc w/ spontaneous bleeding. 1-5% moderate, can still have spontaneous bleed. 5-40% can bleed w/procedures or trauma
Hx includes hemarthrosis, bleeding into joints, and/or x-linked FH of problems: Factor IX deficiency; FVIII deficiency
FVIII & FIX deficiency findings Labs: aPTT prolonged; FVIII/FIX levels decreased
FVIII & FIX deficiency mgmt Specific factor replacements: FVIII or FIX concentrate (plasma derived or recombinant). Avoid IM injections or meds causing bleeding.
FVIII Inhibitor Seen in PG & the elderly; Presents with provoked – spontaneous bleeding; Rare ( 1:1,000,000); Auto-Ab vs FVIII, prevents fn or increasing clearance
Treatment to Eradicate FVIII Inhibitor: Steroids +/- Cyclophosphamide. Tx if Bleeding: If inhibitor is of low titer, can give FVIII; if titer is high, give FVIIa
limited to mucocutaneous bleeding vW Dz
Functions of von Willebrand factor Bridges platelets together and with endothelium. Carrier for FVIII, extending its half-life
von Willebrand disease tx (for mild forms): Avoid aspirin. DDAVP (synthetic vasopressin), intranasal or IV -> increase release of pre-formed vWF (only works for a day or two). e-aminocaproic acid works by inhibiting fibrinolysis
von Willebrand disease tx (for Severe Bleeding/Surgery): Replace with VWF:FVIII containing concentrates; Humate-P. DDAVP pre-op?
Coagulation dz: causes elevated levels of prothrombin; leads to a modest increase in hypercoagulability, (2-fold) Prothrombin 20210A Mutation
Second most common inherited cause of hyper-coaguability Prothrombin 20210A Mutation
Prothrombin 20210A Mutation: concomitant risk factors Smoking, BPCs/Hormone replacement
Fibrinolysis/Anti-coagulant Disorders usu present as: thrombosis
Antithrombin activity is markedly stimulated by: Heparin
Antithrombin def is manifested by: Recurrent venous thromboses
Protein C or Protein S Def: Predisposition to: recurrent venous thromboses
Uncommon causes of venous thromboses Antithrombin def; Protein C or Protein S Def
Disease in which mutation causes resistance to inactivation by Activated Protein C Factor V Leiden
Most common hereditary hyper-coagulable state; mainly limited to ? Factor V Leiden; pts of Euro extraction
Factor V Leiden: Heterozygous state increases risk of thrombosis up to: 8-fold
Factor V Leiden: Homozygous state increases risk: 100-fold
Auto-antibody that interferes with the natural anti-coagulant system Anti-Phospholipid Syndrome
Anti-Phospholipid Syndrome presents with: Recurrent arterial or venous thromboses; 2nd trimester miscarriages; Thrombocytopenia; Valvular heart dz
Anti-Phospholipid Syndrome: Lab Data: Presents w/prolonged aPTT (b/c in vitro fx of the Ab on aPTT); mixing study fails to normalize; Confirmatory tests required to make the diagnosis
Anti-Phospholipid Syndrome: tx Once thrombotic event occurs, tx w/warfarin indefinitely
Condition in which circulating plasma (which contains clotting factors) turns into serum DIC
DIC: presentation Excessive thrombosis (small-midsize vessels: organ infarcts); organ dysfunction (renal; hepatic; CNS: hematuria, GIB, petechiae); bleeding, shock, death
Acral ischemia seen in: DIC
Hx pos for heparin, tacrolimus, ticlopidine may point to: DIC
Signs of hemorrhage in DIC Mucous membranes; IV Sites, catheters, ETT; venipuncture sites
DIC tx (if bleeding, or surgery needed) Platelets. PRBCs. Fibrinogen if <100 (Give cryo: worsen thrombosis if given alone, as cryo lacks AT and proteins C & S)
Defn Hemorrhage: failure to maintain hemostasis
Defn Thrombosis: failure to maintain fluidity
Steps in forming the primary hemostatic plug: Platelet adhesion; platelet aggregation; platelet surface activation & recruitment of other platelets; platelet release
Thromboxane A2 is: a potent stimulator of platelet aggregation & vasoconstriction
Visible end product of coagulation = Fibrin
DIC tx Treat underlying condition. Replace blood products PRN (platelets, FFP, cryo for fibrinogen, PRBCs, ATIII). Possibly heparin or LMWH
Most common congenital disorder of hemostasis von Willebrand (prevalence 1%) (2nd: hemophilia A)
von Willebrand genetics autosomal dominant
von Willebrand factor is carrier protein for: factor VIII. vWF patients have decreased factor VIII levels & prolonged PTT
Glanzmann syndrome = rare autosomal recessive. Deficiency in factors IIb/IIIa; platelets cannot aggregate. High bleeding time.
Tx for Glanzmann syndrome platelet transfusion
Liver is the site of production of all clotting factors except: factor VIII
Thrombopathies Von Willebrand. Glanzmann thrombasthenia. Bernard-Soulier. Acquired
Tx for liver dz/thrombocytopenia FFP +/- cryoprecipitate (contains concentrated fibrinogen)
Causes of acquired thrombopathy Drugs (ASA, NSAIDS, cephalosporins); ETOH (>BT, >*PT, PTT also prolonged in end-stage liver dz); Renal dz (unknown mechanism); Dysproteinemias or MM
Defn Thrombopathy (Qualitative) Bleeding disorders characterized by prolonged BT despite normal platelet count
Subacute DIC (Trousseau syndrome): will see: Recurrent superficial & DVTs; low platelet & high D-dimer
Natural anticoagulants Proteins C & S
Causes of vitamin K deficiency biliary tract disease, drugs (Abx, warfarin), malnutrition, malabsorption
Fibrinogen unique to: plasma; ref range = 206-382
Factor Xa to monitor: LMWH
Hemophilia A & B clinical features Hemarthroses (knees, ankles, elbows). Arthralgias. Low FVIIIc; high PTT.
Hemophilia B clinical features Christmas disease. X linked recessive; males; low FIX; high PTT. Tx = Factor IX, NO DDAVP, NO ASPIRIN
Lupus Anticoagulant Circulating IgG or IgM; high PTT (no correction with mixing studies); risk of thrombosis or recurrent spontaneous abortion
Most frequent cause of hereditary thrombophilia Factor V Leiden (AKA APC); hereditary resistance to action of activated protein C (4-8% of pop)
Diff btw hep & LMWH Hep binds to anti-thrombin III (inactivate coag factors); LMWH binds to ATIII and directly inactivates Xa
D-Dimer Nonspecific; only neg test is helpful; PE; 90% pts w/thrombotic & thromboembolic dz; Neg <0.349; Low Pos = 0.350-0.500; Positive = >0.500
Protein C def pts warfarin hyper-sensitivity rxn; may have to decrease coumadin by half (lest get necrotizing condition)
ACT Activated clotting time; monitors heparin in OR (check if safe to pull cath/A lines); Normal blood clots in <100 seconds; Heparin therapeutic = 300-600 s
Virchow's Triad Vascular damage; Hypercoagulability; Vascular Stasis; Predisposes patient to venous thrombosis
Distinguish liver disease coagulopathy from vitamin K deficiency Vitamin K deficiency only: 5 is normal, 7 is low. Liver disease only: both 5 & 7 are low
Spontaneous hemarthrosis may be sx of: Hemophilia A
Mucosal or gingival bleeding, epistaxis, menorrhagia Von Willebrand dz
Continuous bleeding post-op or trauma; s/p multiple blood transfusions; low platelets, increased PT, INR, + fibrin split products (increased D-dimer): DIC
Coag pathways Intrinsic 12, 11, 9, 8; extrinsic 7; common 1,2,5, 10
thrombopathy genetics von W auto dominant. Glanzmann and Bernard-Soulier auto recessive
Trousseau syndrome = subacute DIC in cancer pts
hemophilia C factor XI: x linked recessive, Ashkenazi; long PTT
Vit K-dependent factors 2, 7, 9, 10
heritable hypercoagulable states Factor V Leiden; pro C & S deficiency; antithrombin III deficiency
Hereditary resistance to action of activated protein C = Factor V Leiden (APC resistance)
Deficiency allows unopposed conversion of fibrinogen to fibrin = Antithrombin III deficiency
giant plts; auto rec; no von W factors Bernard-Soulier dz
Most common severe bleeding disorder hemophilia A (low VIIIc)
Hemophilia C (factor XI def) tx FFP
Von Willebrand Dz tx: ddAVP (synthetic vasopressin); avoid aspirin
Most common congenital coagulopathy von Will (1% prevalence)
Vitamin K deficiency is seen in: HDN (tx with vitamin K). Malabsorption (of fat soluble vitamins: A,D,E, K). Malnutrition. Abx use
Recurrent arterial or venous thromboses; 2nd trimester miscarriages; thrombocytopenia; valvular heart dz; suggests: Anti-Phospholipid Syndrome
fibrin is digested by plasmin
vWF is synthesized in: endothelial cells & megakaryocytes
Function of vWF: mediate platelet adhesion to damaged vessel site
Bernard-Soulier Syndrome Rare autosomal rec; low/abn plt vWF receptor; giant plts, thrombocytopenia, prolonged BT
The ___ pathway initiates coag process; then _____ pathway enhances _____ formation in clot Extrinsic; intrinsic; thrombin
First factors to be affected in hepatic dysfunction Vit K dependent factors (2, 7, 9 & 10) + factor 5
DIC pathology Consumption of coag factors 2/2 intravascular activation of coag process with secondary activation of fibrinolysis -> hemorrhage or thrombosis
Common causes of DIC Infectio (often GNR endotoxins), PG complications, massive tissue injury, hypoxia, acidosis, malignancy, snakebite, acute promyelocytic leukemia (M3 variant of AML)
Hemophilia A epidemiology X linked recessive: Males. 1 in 10,000 live births. 80% of hemophilia patients have Hemo A.
Hemophilia B epidemiology X linked recessive: Males. 1 in 30,000 live births.
Hemophilia A mgmt Factor VIII. DDAVP (transient rise in FVIII, leads to tachyphylaxis)
Portal HTN can lead to: splenomegaly, mild thrombocytopenia, varices, PUD, GI bleed
Antithrombin III (ATIII) deficiency pathology ATIII inactivates surplus thrombin. Activity potentiated by heparin. ATIII deficiency (AD or acquired) -> venous thrombosis
ATIII deficiency mgmt If VTE: IV heparin -> PO warfarin indefinitely
Protein C deficiency pathology Protein C = vit K-dependent liver protein to stimulate fibrinolysis & clot lysis. Deficiency -> recurrent VTE & PE.
Protein C deficiency clinical features Warfarin-induced skin necrosis. Purpura fulminans or fulminant intravascular coagulation in newborns. Possibly CVA.
Protein C deficiency mgmt IV heparin -> PO warfarin indefinitely
What % of patients with DVT/PE have cancer? 15% (another 5% without cancer dx will have cancer dx within 1 year)
Created by: Abarnard

Browse or Search millions of existing flashcards     Create Flashcards plus a dozen other activities